Artrya Overview
- Year Founded
-
2019
- Status
-
Public
- Employees
-
35
- Stock Symbol
-
AYA
- Share Price
-
$2.17
- (As of Friday Closing)
Artrya General Information
Description
Artrya Ltd is engaged in the development and commercialisation of its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The Salix technology platform is the core of the Company, leveraging proprietary artificial intelligence to deliver a rapid, automated assessment of a patient's coronary CT angiogram (CCTA). The Company operates in a single segment, being the development of AI-driven CCTA image analysis technology.
Contact Information
Website
www.artrya.comCorporate Office
- 1257 Hay Street West
- Perth, Western Australia 6005
- Australia
Corporate Office
- 1257 Hay Street West
- Perth, Western Australia 6005
- Australia
Artrya Timeline
Artrya Stock Performance
As of 13-Nov-2026, Artrya’s stock price is $2.17. Its current market cap is $356M with 164M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.17 | $2.35 | $1.40 - $4.50 | $356M | 164M | 1.44M |
Artrya Financials Summary
As of 30-Sep-2026, Artrya has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 355,958 | 631,662 | 48,754 | 1,973 |
| Revenue | 19 | 18 | ||
| EBITDA | (17,847) | (9,980) | (8,129) | |
| Net Income | (17,060) | (10,615) | (9,175) | |
| Total Assets | 58,737 | 15,465 | 12,708 | |
| Total Debt | 170 | 408 | 634 |
Artrya Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Artrya Comparisons
Industry
Financing
Details
Artrya Competitors (1)
One of Artrya’s competitors is HeartFlow, a Formerly VC-backed company based in Mountain View, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| HeartFlow | Formerly VC-backed | Mountain View, CA |
Artrya Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Artrya Patents
Artrya Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2026905555-A0 | A system for and method of analysing blood flow through coronary arteries | Pending | 16-Jun-2026 | ||
| AU-2025900355-A0 | A system for and method of analysing blood flow through coronary arteries | Pending | 10-Feb-2025 | ||
| AU-2024902678-A0 | A system for and method of plaque scoring of coronary arteries | Inactive | 27-Aug-2024 | ||
| AU-2025234068-A1 | A method of and system for plaque scoring of coronary arteries | Pending | 08-Mar-2024 | ||
| WO-2025184701-A1 | A method of and system for plaque scoring of coronary arteries | Pending | 08-Mar-2024 | A61B6/504 |
Artrya Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Artrya Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Artrya ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Software & Services
Industry
Rank
Percentile
Enterprise and Infrastructure Software
Subindustry
Rank
Percentile
Artrya FAQs
-
When was Artrya founded?
Artrya was founded in 2019.
-
Where is Artrya headquartered?
Artrya is headquartered in Perth, Australia.
-
What is the size of Artrya?
Artrya has 35 total employees.
-
What industry is Artrya in?
Artrya’s primary industry is Decision/Risk Analysis.
-
Is Artrya a private or public company?
Artrya is a Public company.
-
What is Artrya’s stock symbol?
The ticker symbol for Artrya is AYA.
-
What is the current stock price of Artrya?
As of 13-Nov-2026 the stock price of Artrya is $2.17.
-
What is the current market cap of Artrya?
The current market capitalization of Artrya is $356M.
-
Who are Artrya’s competitors?
HeartFlow is a competitor of Artrya.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
